Cholesterol
Supplements touting CV benefits may be ‘harmful distraction’ from proven solutions
Dietary supplements are big business in the United States and elsewhere, especially when it comes to products marketed to support CV health.
Where do we go from CLEAR?
In the past decade, there have been major advances in lipid-lowering therapeutics, and another was made apparent in March at the American College of Cardiology Scientific Session.
Inflammatory risk better predicts events vs. cholesterol risk in statin-treated patients
NEW ORLEANS — In high-risk patients on statin therapy, residual inflammatory risk as assessed by high-sensitivity C-reactive protein better predicted CV events and death than residual cholesterol risk as assessed by LDL, data show.
‘Potential cardiovascular risk’ for some on keto-style diet
NEW ORLEANS — Certain traditional risk factors including severe high cholesterol, diabetes, hypertension and smoking may increase CV risk among those following a low-carbohydrate, high-fat “keto-style diet,” a speaker reported here.
High total cholesterol may increase risk for future asthma in children
SAN ANTONIO — Children with high levels of total cholesterol may be at risk for asthma later in life, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Top in cardiology: ChatGPT for CVD prevention; ‘food swamps’
A research version of the artificial intelligence language model ChatGPT provided appropriate recommendations for most CVD queries, according to findings published in JAMA.
ChatGPT model provides appropriate recommendations for most CVD prevention queries
A research version of the artificial intelligence language model ChatGPT appropriately responded to a majority of suggested CVD prevention questions, including complex topics like cholesterol management despite statin therapy.
General CVD risk prediction tools appear to be useful for cancer survivors
CVD risk prediction tools developed for a primary care population in New Zealand were similarly useful risk predictors for adult cancer survivors, researchers reported.
USPSTF: Evidence is insufficient to support lipid disorder screening in asymptomatic kids
There is not yet enough evidence to adequately assess the benefit-harm balance of screening for lipid disorders in asymptomatic children and adolescents aged 20 years or younger, according to a statement from the U.S. Preventive Services Task Force.
Positive dose-response association between dietary cholesterol, type 2 diabetes incidence
Researchers observed a positive dose-response association between dietary cholesterol and type 2 diabetes incidence, particularly in Western countries, according to a meta-analysis of prospective cohort studies.